Sunshine Biopharma Stock Price History
| SBFM Stock | USD 2.71 0.18 6.23% |
Below is the normalized historical share price chart for Sunshine Biopharma extending back to October 30, 2009. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Sunshine Biopharma stands at 2.71, as last reported on the 12th of December 2024, with the highest price reaching 2.92 and the lowest price hitting 2.70 during the day.
If you're considering investing in Sunshine Stock, it is important to understand the factors that can impact its price. As of now, Sunshine Stock is very risky. Sunshine Biopharma owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.018, which indicates the firm had a 0.018% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Sunshine Biopharma, which you can use to evaluate the volatility of the company. Please validate Sunshine Biopharma's Coefficient Of Variation of 3543.53, semi deviation of 4.61, and Risk Adjusted Performance of 0.0291 to confirm if the risk estimate we provide is consistent with the expected return of 0.1%.
At this time, Sunshine Biopharma's Total Stockholder Equity is very stable compared to the past year. As of the 12th of December 2024, Liabilities And Stockholders Equity is likely to grow to about 28.7 M, while Common Stock is likely to drop about 26.6 K. . As of the 12th of December 2024, Price Earnings To Growth Ratio is likely to grow to 0.02, while Price To Sales Ratio is likely to drop 0.26. Sunshine Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 30th of October 2009 | 200 Day MA 30.9142 | 50 Day MA 2.8432 | Beta (1.04) |
Sunshine |
Sharpe Ratio = 0.018
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | SBFM | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.69 actual daily | 50 50% of assets are less volatile |
Expected Return
| 0.1 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Sunshine Biopharma is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sunshine Biopharma by adding it to a well-diversified portfolio.
Price Book 0.2309 | Enterprise Value Ebitda (7.73) | Price Sales 0.1808 | Shares Float 2 M | Wall Street Target Price 300 |
Sunshine Biopharma Stock Price History Chart
There are several ways to analyze Sunshine Stock price data. The simplest method is using a basic Sunshine candlestick price chart, which shows Sunshine Biopharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | September 23, 2024 | 3.34 |
| Lowest Price | November 21, 2024 | 2.12 |
Sunshine Biopharma December 12, 2024 Stock Price Synopsis
Various analyses of Sunshine Biopharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Sunshine Stock. It can be used to describe the percentage change in the price of Sunshine Biopharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Sunshine Stock.| Sunshine Biopharma Accumulation Distribution | 8,063 | |
| Sunshine Biopharma Price Daily Balance Of Power | (0.82) | |
| Sunshine Biopharma Price Rate Of Daily Change | 0.94 | |
| Sunshine Biopharma Price Action Indicator | (0.19) |
Sunshine Biopharma December 12, 2024 Stock Price Analysis
Sunshine Stock Price History Data
The price series of Sunshine Biopharma for the period between Fri, Sep 13, 2024 and Thu, Dec 12, 2024 has a statistical range of 1.22 with a coefficient of variation of 9.27. The price distribution for the period has arithmetic mean of 2.88. The median price for the last 90 days is 2.94. The company completed stock split (1:20) on 8th of August 2024. Sunshine Biopharma had dividends distributed to its stock-holders on 2020-04-06.| Open | High | Low | Close | Volume | ||
| 12/12/2024 | 2.89 | 2.92 | 2.70 | 2.71 | 107,018 | |
| 12/12/2024 | 2.89 | 2.92 | 2.70 | 2.71 | 107,018 | |
| 12/10/2024 | 2.90 | 2.96 | 2.81 | 2.89 | 154,447 | |
| 12/09/2024 | 3.43 | 3.44 | 2.89 | 2.98 | 525,713 | |
| 12/06/2024 | 3.14 | 3.44 | 3.12 | 3.34 | 489,993 | |
| 12/05/2024 | 3.35 | 3.48 | 3.01 | 3.23 | 2,058,910 | |
| 12/04/2024 | 2.83 | 3.06 | 2.82 | 2.97 | 2,091,458 | |
| 12/03/2024 | 3.17 | 3.17 | 2.79 | 2.79 | 210,334 | |
| 12/02/2024 | 2.93 | 3.15 | 2.72 | 3.10 | 526,217 | |
| 11/29/2024 | 2.77 | 2.91 | 2.71 | 2.86 | 143,377 | |
| 11/27/2024 | 3.18 | 3.32 | 2.70 | 2.73 | 552,331 | |
| 11/26/2024 | 2.38 | 3.10 | 2.38 | 3.04 | 1,554,873 | |
| 11/25/2024 | 2.30 | 2.56 | 2.20 | 2.44 | 753,492 | |
| 11/22/2024 | 2.32 | 3.04 | 2.18 | 2.36 | 26,929,506 | |
| 11/21/2024 | 2.18 | 2.20 | 2.11 | 2.12 | 49,336 | |
| 11/20/2024 | 2.29 | 2.34 | 2.18 | 2.18 | 52,718 | |
| 11/19/2024 | 2.29 | 2.32 | 2.20 | 2.28 | 64,589 | |
| 11/18/2024 | 2.34 | 2.38 | 2.27 | 2.29 | 61,270 | |
| 11/15/2024 | 2.56 | 2.66 | 2.25 | 2.35 | 311,442 | |
| 11/14/2024 | 2.55 | 2.59 | 2.52 | 2.57 | 42,608 | |
| 11/13/2024 | 2.65 | 2.71 | 2.55 | 2.56 | 100,371 | |
| 11/12/2024 | 2.62 | 2.73 | 2.59 | 2.63 | 104,074 | |
| 11/11/2024 | 2.67 | 2.73 | 2.59 | 2.61 | 128,731 | |
| 11/08/2024 | 2.74 | 2.79 | 2.65 | 2.69 | 76,117 | |
| 11/07/2024 | 2.65 | 2.86 | 2.58 | 2.72 | 191,291 | |
| 11/06/2024 | 2.76 | 2.83 | 2.60 | 2.68 | 278,954 | |
| 11/05/2024 | 2.93 | 2.93 | 2.81 | 2.86 | 639,452 | |
| 11/04/2024 | 2.81 | 2.91 | 2.80 | 2.89 | 56,522 | |
| 11/01/2024 | 2.80 | 2.95 | 2.80 | 2.84 | 52,708 | |
| 10/31/2024 | 2.90 | 2.90 | 2.77 | 2.82 | 113,247 | |
| 10/30/2024 | 3.00 | 3.00 | 2.82 | 2.85 | 132,101 | |
| 10/29/2024 | 2.91 | 2.95 | 2.86 | 2.89 | 94,028 | |
| 10/28/2024 | 3.03 | 3.09 | 2.90 | 2.95 | 187,678 | |
| 10/25/2024 | 3.02 | 3.09 | 2.98 | 3.02 | 102,396 | |
| 10/24/2024 | 3.03 | 3.08 | 2.97 | 3.01 | 56,326 | |
| 10/23/2024 | 3.14 | 3.14 | 2.98 | 3.04 | 95,048 | |
| 10/22/2024 | 3.04 | 3.19 | 3.00 | 3.14 | 188,664 | |
| 10/21/2024 | 2.97 | 3.10 | 2.97 | 3.06 | 59,809 | |
| 10/18/2024 | 2.95 | 3.01 | 2.95 | 3.01 | 29,752 | |
| 10/17/2024 | 3.01 | 3.03 | 2.94 | 3.00 | 46,731 | |
| 10/16/2024 | 3.01 | 3.05 | 2.93 | 2.98 | 95,238 | |
| 10/15/2024 | 2.97 | 2.98 | 2.85 | 2.95 | 79,138 | |
| 10/14/2024 | 2.98 | 3.07 | 2.92 | 3.01 | 90,903 | |
| 10/11/2024 | 3.03 | 3.12 | 2.92 | 2.97 | 70,662 | |
| 10/10/2024 | 3.01 | 3.07 | 2.98 | 3.06 | 26,544 | |
| 10/09/2024 | 2.95 | 3.01 | 2.95 | 3.00 | 35,597 | |
| 10/08/2024 | 3.09 | 3.09 | 2.92 | 2.94 | 62,245 | |
| 10/07/2024 | 3.19 | 3.19 | 2.95 | 3.02 | 95,453 | |
| 10/04/2024 | 2.94 | 3.19 | 2.94 | 3.17 | 135,338 | |
| 10/03/2024 | 2.92 | 3.05 | 2.91 | 2.98 | 46,427 | |
| 10/02/2024 | 3.05 | 3.06 | 2.83 | 2.93 | 170,853 | |
| 10/01/2024 | 3.12 | 3.15 | 3.02 | 3.08 | 82,190 | |
| 09/30/2024 | 3.20 | 3.22 | 3.11 | 3.18 | 71,968 | |
| 09/27/2024 | 3.15 | 3.22 | 3.07 | 3.20 | 73,194 | |
| 09/26/2024 | 3.00 | 3.14 | 2.87 | 3.07 | 198,442 | |
| 09/25/2024 | 3.07 | 3.09 | 2.82 | 2.87 | 235,978 | |
| 09/24/2024 | 3.34 | 3.35 | 3.00 | 3.03 | 381,921 | |
| 09/23/2024 | 3.16 | 3.50 | 3.05 | 3.34 | 393,046 | |
| 09/20/2024 | 3.28 | 3.75 | 3.07 | 3.16 | 685,027 | |
| 09/19/2024 | 3.28 | 3.44 | 3.01 | 3.30 | 2,771,294 | |
| 09/18/2024 | 2.88 | 3.20 | 2.84 | 2.99 | 432,114 |
About Sunshine Biopharma Stock history
Sunshine Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Sunshine is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Sunshine Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Sunshine Biopharma stock prices may prove useful in developing a viable investing in Sunshine Biopharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 12.2 K | 8.8 K | |
| Net Loss | -24.1 M | -22.9 M |
Sunshine Biopharma Stock Technical Analysis
Sunshine Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Global Markets Map Now
Global Markets MapGet a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
| All Next | Launch Module |
Sunshine Biopharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Sunshine Biopharma's price direction in advance. Along with the technical and fundamental analysis of Sunshine Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Sunshine to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0291 | |||
| Jensen Alpha | 0.1909 | |||
| Total Risk Alpha | (0.73) | |||
| Sortino Ratio | 0.0068 | |||
| Treynor Ratio | (0.38) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sunshine Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. To learn how to invest in Sunshine Stock, please use our How to Invest in Sunshine Biopharma guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sunshine Biopharma. If investors know Sunshine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sunshine Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (127.90) | Revenue Per Share 197.42 | Quarterly Revenue Growth 0.416 | Return On Assets (0.11) | Return On Equity (0.18) |
The market value of Sunshine Biopharma is measured differently than its book value, which is the value of Sunshine that is recorded on the company's balance sheet. Investors also form their own opinion of Sunshine Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Sunshine Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sunshine Biopharma's market value can be influenced by many factors that don't directly affect Sunshine Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sunshine Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sunshine Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sunshine Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.